SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-24-019698
Filing Date
2024-06-07
Accepted
2024-06-07 17:05:48
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 mbrx20240602_s3.htm S-3 287928
2 EXHIBIT 4.1 ex_684422.htm EX-4.1 511801
3 EXHIBIT 4.2 ex_684423.htm EX-4.2 537137
4 EXHIBIT 5 ex_684817.htm EX-5 35856
5 EXHIBIT 23.1 ex_683404.htm EX-23.1 2568
6 EXHIBIT FILING FEES ex_684479.htm EX-FILING FEES 126117
7 afs01.jpg GRAPHIC 10387
8 afs02.jpg GRAPHIC 4385
9 moleculinnewlogoresized.jpg GRAPHIC 7783
  Complete submission text file 0001437749-24-019698.txt   1533827
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-280064 | Film No.: 241030554
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)